Changes In Personnel At Pfizer
Following the retirement of Robert Neimeth as vice president of Pfizer Inc and president of the International Pharmaceuticals Group at Pfizer of the USA, the company has reorganized its business to form the Pfizer Pharmaceuticals Group, headed by Henry McKinnell (Marketletter October 7).
Additional changes to become effective from January 1, 1997, are as follows:
David Shedlarz is elected senior vice president, Pfizer Inc; Karen Katen and Vic Micati to become executive vice presidents of Pfizer Pharmaceuticals Group; Mohand Sidi Said becomes senior vice president and area president, Asia/Africa/Middle East; Ian Read is appointed senior vice president and area president, Canada/Latin America; Robert Norton becomes senior vice president, employee resources; Hugh O'Conner to senior vice president, operations and planning; and Gary Jortner and Evan Norris are elected vice presidents, product development Pfizer Pharmaceuticals Group.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze